This is the first time we’ve had access to an influenza genome from the 1918–1920 pandemic in Switzerland. It opens up new insights into the dynamics of how the virus adapt ...

Vaccines remain the best defense against COVID-19 and influenza, with the flu vaccine mainly targeting two proteins on the virus’s surface. Researchers in ACS Central Science report that simulations ...

Yuta Tsukamoto et. al. Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication. Science, 2023 DOI: 10.1126/science.add0875 ...

Scientists have successfully decoded the genome of the 1918 influenza virus from a preserved Swiss patient sample. The research reveals that the virus already possessed key adaptations for human hosts ...

Influenza is a common respiratory virus that is categorized into four types: A, B, C and D. Type C only causes mild infections and type D is not believed to infect humans.

Influenza requires cellular enzyme for replication The enzyme MTr1 provides cellular mRNA with a cap structure and thus functions as the cell's "nucleic acid labeler".

Researchers from the universities of Basel and Zurich have used a historical specimen from UZH's Medical Collection to decode ...

Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA) protein head. The ...

Scientists have discovered that H5N1, the strain of highly pathogenic avian influenza virus currently spreading in U.S. dairy cows, only needs a single mutation to readily latch on to human cells ...

Avian influenza A(H5N1) virus is spreading through dairy herds across the United States. In this report, wastewater surveillance shows the increase of H5N1 across 10 urban communities.